Many women struggle with symptoms of postpartum depression after giving birth, and many can suffer in silence. Despite being one of the most common medical conditions, PPD is underrecognized and underdiagnosed. Sage Therapeutics is working to fix that. The company, in collaboration with Biogen, developed the first-and-only oral treatment specifically indicated for adults with postpartum depression. Sage is also working to destigmatize the disease and increase access to treatment for patients.
In honor of Women’s Health Month, I sat down with Vanessa Procter, Senior Vice President of External Affairs at Sage, to discuss the importance of maternal mental health. Watch our conversation to learn more about treating PPD and how we can support this type of innovation.
Elizabeth Carpenter
Elizabeth Carpenter serves as executive vice president of policy and research for the Pharmaceutical Research and Manufacturers of America (PhRMA).
Carpenter leads policy and research at PhRMA, focusing on policy analysis, original research and policy development. Previously, she spent 10 years at the health policy and business strategy firm, Avalere, most recently serving as president. Prior to joining Avalere, Carpenter was a senior advisor in the health policy practice at McKenna Long & Aldridge LLP, where she provided government affairs and public policy support to payers, providers, private exchanges, and states on a wide range of health policy and political issues.
Previously, she served as the associate policy director for the Health Policy Program at the New America Foundation where she led Congressional and media relations during the debate over the ACA and provided educational and technical support to stakeholders, members of Congress and the media. Carpenter started her career on Capitol Hill on the legislative and campaign staffs of Senator Lincoln Chafee (RI).
Elizabeth Carpenter headshot
https://www.linkedin.com/in/elizabethavalere/
Executive Vice President, Policy and Research
Bayh-Dole: The fuel for America’s innovation engine
ICYMI: Biopharmaceutical companies in America hit new investment milestone
World Sickle Cell Day: Recognizing the promise of gene therapy
America's cancer research progress is real and worth protecting
Women’s Health Month: A conversation with Sage
Health Equity
Mental Health
Research and Development
Women’s Health Month: A conversation with Sage
Women’s Health Month: A conversation with Sage